Form D · Other Health Care
Vesta Medical LLC d/b/a Vestara
Irvine, CA · CIK 0001369354
Offering snapshot reported Feb 1, 2011 · SEC filing
- Reported sold
- $6.23M Offering amount: $10M
- Investors reported
- 139 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- May 15, 2009 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$4,040,825 → $6,225,932
- Reported investors98 → 139
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 1, 2011 | Amendment | $6,225,932 | $2,185,107vs Jun 15, 2010 | 139 | SEC filing |
| Jun 15, 2010 | Amendment | $4,040,825 | $684,865vs May 5, 2010 | 98 | SEC filing |
| May 5, 2010 | Amendment | $3,355,960 | $425,000vs Mar 18, 2010 | 81 | SEC filing |
| Mar 18, 2010 | Amendment | $2,930,960 | $818,000vs Jan 6, 2010 | 72 | SEC filing |
| Jan 6, 2010 | Amendment | $2,112,960 | $1,222,618vs Aug 14, 2009 | 54 | SEC filing |
| Aug 14, 2009 | Initial | $890,342 | No comparison | 13 | SEC filing |
| Sep 24, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 11, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 3, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $850K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-91928
Total offering size does not include up to $15,400,000 in proceeds from future exercises of warratns issued in this Offering and covered by this Form D
Sales commissions are calculated as follows: (i) 6.5% placement fee on the principal amount of notes sold; and (ii) 2% managing dealer fee on gross Offering proceeds.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Waveland Capital Partners LLC | 40054 | Waveland Capital Partner LLC · CRD 40054 |
| Eagle One Investments LLC | 45254 | Eagle One Investments LLC · CRD 45254 |
| Kalos Capital Inc. | 44337 | Kalos Capital Inc. · CRD 44337 |
| VSR Financial Services Inc. | 14503 | VSR Financial Services Inc. · CRD 14503 |
| MCL Financial Group, Inc. | 41180 | MCL Financial Group, Inc. · CRD 41180 |
Source: Form D, filed Feb 1, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Arthur Bertolero | Director |
| Alan Davidner | Director |
| Michael J Greer | Director |
| Scott R Mallett | Executive |
| Michael J Martin | Director |
| William E Maya | Executive |
| Robert Morris | Director |
| John K Stroh | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1555 A Mc Gaw Avenue
Irvine, CA, 92614
Irvine, CA, 92614